- Home
- OKE vs BDX Comparison
OKE vs BDX Comparison
Compare OKE & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKE
- BDX
- Stock Information
- Founded
- OKE 1906
- BDX 1897
- Country
- OKE United States
- BDX United States
- Employees
- OKE N/A
- BDX N/A
- Industry
- OKE Oil & Gas Production
- BDX Medical/Dental Instruments
- Sector
- OKE Utilities
- BDX Health Care
- Exchange
- OKE Nasdaq
- BDX Nasdaq
- Market Cap
- OKE 54.9B
- BDX 58.9B
- IPO Year
- OKE N/A
- BDX 1962
- Fundamental
- Price
- OKE $80.75
- BDX $172.57
- Analyst Decision
- OKE Buy
- BDX Buy
- Analyst Count
- OKE 14
- BDX 9
- Target Price
- OKE $104.00
- BDX $235.63
- AVG Volume (30 Days)
- OKE 3.5M
- BDX 3.6M
- Earning Date
- OKE 04-29-2025
- BDX 05-01-2025
- Dividend Yield
- OKE 5.10%
- BDX 2.41%
- EPS Growth
- OKE 18.10
- BDX 14.07
- EPS
- OKE 5.11
- BDX 5.16
- Revenue
- OKE $24,960,000,000.00
- BDX $20,867,000,000.00
- Revenue This Year
- OKE $29.67
- BDX $9.28
- Revenue Next Year
- OKE $2.22
- BDX $4.92
- P/E Ratio
- OKE $15.82
- BDX $33.43
- Revenue Growth
- OKE 39.15
- BDX 5.84
- 52 Week Low
- OKE $75.48
- BDX $163.33
- 52 Week High
- OKE $118.07
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- OKE 40.02
- BDX 38.31
- Support Level
- OKE $78.57
- BDX $169.60
- Resistance Level
- OKE $82.38
- BDX $176.43
- Average True Range (ATR)
- OKE 1.69
- BDX 3.46
- MACD
- OKE -0.11
- BDX 1.54
- Stochastic Oscillator
- OKE 18.76
- BDX 40.36
About OKE ONEOK Inc.
Oneok is a diversified midstream service provider specializing in natural gas gathering, processing, storage, and transportation and natural gas liquids transportation and fractionation. It also operates a refined product and crude oil segment connecting producers, refiners, and consumers. Operations are in the midcontinent, Permian, and Rocky Mountain regions.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.